Patents by Inventor Heidi Kidron

Heidi Kidron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE VAP-1 AND USES THEREOF
    Publication number: 20110021760
    Abstract: The present invention relates to crystalline vascular adhesion protein-1 (VAP-1) and in particular to methods for the use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, as well as screening assays for detections of same. The invention further relates to inhibitors identified by the assays according to the present invention.
    Type: Application
    Filed: January 8, 2009
    Publication date: January 27, 2011
    Inventors: Tiina SALMINEN, Tomi Airenne, Mark Johnson, Heidi Kidron, Yvonne Nymalm-Rejstrom, Annu Sõderholm, David Smith, Marjo Pihlavisto, Lenita Viitanen, Olli Pentikãinen, Tommi Nyrônen
  • Crystalline VAP-1 and uses thereof
    Patent number: 7499847
    Abstract: The present invention relates to crystalline vascular adhesion protein-1 (VAP-1) and in particular to methods for the use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, as well as screening assays for detection of same. The invention further relates to inhibitors identified by the assays according to the present invention.
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: March 3, 2009
    Assignee: Biotie Therapies Corporation
    Inventors: Tiina Salminen, Tomi Airenne, Mark Johnson, Heidi Kidron, Yvonne Nymalm-Rejström, Annu Söderholm, David Smith, Marjo Pihlavisto, Lenita Viitanen, Olli Pentikäinen, Tommi Nyrönen
  • Crystalline vap-1 and uses thereof
    Publication number: 20070093646
    Abstract: The present invention relates to crystalline vascular adhesion protein-1 (VAP-1) and in particular to methods for the use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, as well as screening assays for detection of same. The invention further relates to inhibitors identified by the assays according to the present invention.
    Type: Application
    Filed: May 25, 2004
    Publication date: April 26, 2007
    Inventors: Tiina Salminen, Tomi Airenne, Mark Johnson, Heidi Kidron, Yvonne Nymalm-Rejstrom, Annu Soderholm, David Smith, Marjo Pihlavisto, Lenita Viitanen, Olli Pentikainen, Tommi Nyronen